Overall error rate (all four criteria combined) for the nonintervention group decreased 4.9% (p> 0.05). Overall 
mended before and in conjunction with LLDs, where its benefit is shown to be additive and its efficacy may be associated with the equivalent of doubling LLD dosage3
Program managers have thus encountered a need to monitor the use of LLDs to achieve optimal therapeutic benefits and cost-effective treatment. This need is driven by the everincreasing number of LLD products and costs of these agents; it is supported by the incidence of suboptimal prescribing, which has become a major cause of drug-related illness. Unfamiliarity with the pharmacology of LLDs In this article, we present background information on studies of prescriber education programs; discuss the need for such efforts with respect to LLDs; and present a study of academic detailing for LLDs in a managed care setting.
STUDIES OF PRESCRIBER EDUCATIONAL EFFORTS
Much research has investigated why physicians routinely overuse, underuse, or inappropriately prescribe medications. 
Self

Error Percentage for the Physician Groups
The error rates reported for the preintervention period are based on 26 physician groups, whereas the error rates reported for the postintervention period, the change in error rate from baseline, and the significance probabilities are based on only 24 physician groups because two groups had no post-test data. The error rates are reported along with their 95% confidence intervals (Cl).
Overall Error Rate
The actual mean (:t S.D.) error rates in the total study de 
Control versus Intervention Groups
The results of the analysis of variance of change scores (Table 4) 
Control versus Treatment Groups
An overall reduction in prescribing errors of 9.8% was statistically significant for the treatment group. This translated. 
